Never Miss Important Company Updates Again
Get AI-powered summaries of SEC filings delivered to your inbox
Follow your favorite stocks and get email alerts when they release important updates. Completely free.
Celcuity Inc. is a biotechnology company specializing in targeted cancer therapies and diagnostic platforms. Its lead drug candidate, gedatolisib, inhibits key pathways involved in tumor growth, focusing on breast and prostate cancers. The company develops and commercializes therapies addressing unmet medical needs, leveraging proprietary IP and diagnostic tools to improve treatment efficacy and patient outcomes in solid tumors.
This description was generated via AI from an annual report. Updated about 1 year ago.